We at Roche Foundation Medicine are dedicated to transforming cancer care and continue to take steps to ensure that advanced cancer patients are receiving personalised care plans based on the results from comprehensive genomic profiling. With this in mind, we would like to introduce our new payment model - the F1-ZiiP (FoundationOne Zero-interest instalment Plan) program.
The F1-ZiiP program allows patient to convert the cost of the FoundationOne test in convenient 6-monthly or 12-monthly instalments at no interest*
*currently for Public Bank and HSBC cardholders only
Alternatively, patient can make full payment for the FoundationOne test with credit/debit card (Visa or Mastercard) directly to us.
If you would like to understand further, you may contact us at firstname.lastname@example.org.